Navigate this market better. Subscribe for FREE stock alerts and information.

Wednesday, September 17, 2014

Market Chatter-Corporate finance press digest - Sept 17, (NASDAQ: SLXP)

The following corporate finance-related stories were reported by media:* Some of the top 20 investors at Salix Pharmaceuticals Ltd are threatening to vote down a proposed deal to purchase a unit of Cosmo Pharmaceuticals SpA, and are pressing Salix to consider selling itself instead, people familiar with the matter said on Tuesday.

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. Shares of SLXP traded higher by 4.81% or $7.15/share to $155.87. In the past year, the shares have traded as low as $65.38 and as high as $162.38. On average, 1383410 shares of SLXP exchange hands on a given day and today's volume is recorded at 2180769.